Skip to main content
Funded Studies

Michael Gordon Kaplitt, MD, PhD

Professor of Neurological Surgery, Vice-Chairman for Research at Weill Cornell Medical College

Location: New York, NY United States

Michael G. Kaplitt, MD, PhD, is Professor and Vice-Chair for Research in the Department of Neurological Surgery at Weill Cornell Medicine. He received a PhD in molecular neurobiology from The Rockefeller University and an MD from Cornell University Medical College.  

An international leader in gene therapy and functional neurosurgery for neurodegenerative disorders, he first described using adeno-associated virus in the mammalian brain in 1994. In 2003, he performed the first human gene therapy for Parkinson’s disease (PD). Dr. Kaplitt has also performed the first gene therapy for a genetic form of Parkinson’s and first induced pluripotent stem cell transplant for PD, among many other translational innovations. 

His lab research focuses on using gene therapy to better understand and treat unmet needs in PD and other neuropsychiatric disorders. His many honors and awards include elected membership in the American Society for Clinical Investigation and the Society for Neurological Surgeons.

Associated Grants

  • Alpha-synuclein Effects on Gut-brain Circuits and Pre-motor Symptoms in Parkinson’s Disease


  • LRRK2 Activity and Dyskinesia Supplement


  • LRRK2 Activity and Dyskinesia


  • Role of LRRK2 in Levodopa-induced Dyskinesia


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.